The New Zealand Competition Authority releases a statement of unresolved issues on a proposed acquisition of an animal health research company by the world's biggest animal drug manufacturer (Zoetis / Jurox)

Competition Authority, New Zealand

Previous article The US DoJ and FTC announce a joint spring enforcers summit to discuss modernizing merger guidelines and interagency collaboration Next article The Indian Competition Authority fines renewable energy firm for gun-jumping (Adani Green / SB Energy)

9 Mar 2022

The New Zealand Competition Authority releases a statement of unresolved issues on a proposed acquisition of an animal health research company by the world’s biggest animal drug manufacturer (Zoetis / Jurox)

KEYWORDS

Reference

New Zealand Competition Authority, Zoetis / Jurox, Press Release, 9 March 2022

Statement of Unresolved Issues released for proposed acquisition of Jurox by Zoetis* The Commerce Commission has published a Statement of Unresolved Issues relating to the application from Zoetis Inc. seeking clearance

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

PDF Version

Author

New Zealand Competition Authority
New Zealand Commerce Commission (Wellington)

New Zealand 120 contributions 18221 visits

Quotation

New Zealand Competition Authority, The New Zealand Competition Authority releases a statement of unresolved issues on a proposed acquisition of an animal health research company by the world’s biggest animal drug manufacturer (Zoetis / Jurox), 9 March 2022, e-Competitions March 2022, Art. N° 106501

Visites 143